and enrollments declined by 7% quarter-over-quarter and about 10% year-over-year. These declines indicate potential issues in market demand and patient acquisition. For fiscal year 2025, Puma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback